Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.
Case Library Membership
Search free — but unlock advanced filters to find every case involving a specific company or clause.
Already a member? Sign in →
Case Library Membership
inc. VAT
inc. VAT · cancel any time
Secure payment via Stripe
Need access for your team?
Company licences available for compliance teams, medical affairs, and training programmes.
Get a team quote →1,930 cases found
Anonymous HCP alleged Roche’s Ocrevus promotional webpage implied only 1 hour monitoring and omitted “dedicated line” administration. Panel found the timeline clearly…
A UK AstraZeneca employee ‘liked’ a third-party LinkedIn post about positive phase 3 datopotamab deruxtecan results. The Panel said the ‘like’ disseminated…
A member of the public challenged GSK’s press release for quoting vaccine “efficacy” percentages without absolute risk/context. PMCPA ruled the presentation could…
Five weight-loss media articles were complained about. Novo Nordisk was not responsible for four. One Sunday Times interview quote was ruled promotional…
PMCPA ruled AstraZeneca breached its undertaking after Symbicort was again referenced on the Trixeo website without Symbicort prescribing information, shortly after an…
Complaint that a Nuvaxovid (POM) web ad appeared without HCP confirmation. Panel found P3 Pharmacy could be an independently produced HCP journal…
Ex-employee alleged an individual promoted medicines to HCPs for 2+ years without ABPI qualification. Panel found no evidence for the 2-year claim…
A complaint alleged an Astellas LinkedIn post was promotional and not properly approved (no job bag/date; liked/shared by sales/marketing). The PMCPA ruled…
An ALK-Abelló representative posted about Jext on Facebook with a link to the product website and urged people to share. PMCPA ruled…
AGB’s Adaflex branded webpage (intended for HCPs) became publicly accessible via a Google-indexed direct link, leading to breaches for website access controls…
Novo Nordisk failed to disclose some transfers of value on time and did not disclose others at all due to HCO misclassification.…
A senior UK employee ‘liked’ an Otsuka US LinkedIn post about unlicensed ulotaront, which the Panel said proactively disseminated promotional claims. Breaches…
A health professional alleged a Lilly representative repeatedly visited a dermatology department without prior authorisation and dropped off items/samples. The Panel found…
Otsuka’s “Therapy Areas in Europe” webpage still referenced working with partner Akebia on CKD anaemia after the agreement ended. PMCPA ruled the…
Complaint alleged repeated brand-name use and patient-record style questions in Abilify Maintena ATU tracking market research (2018–2021). PMCPA Panel found the activity…
Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.
